Etaluma is collaborating with the RegeneratOR Test Bed, a new regenerative medicine endeavor in North Carolina, by providing its technology to help support start-up and early-stage companies in the regenerative medicine space.
Researchers at Wake Forest School of Medicine have been awarded a $580,000 grant from the National Institutes of Health (NIH) HEAL Initiative and the National Cancer Institute (NCI) to develop a culturally and linguistically responsive pain intervention for Spanish-speaking populations.
Researchers at Wake Forest School of Medicine, led by David R. Soto-Pantoja, Ph.D., associate professor of surgery and cancer biology, have discovered blood biomarkers that can potentially predict patient response to immunotherapy in the treatment of melanoma.
A problem long-associated with developing countries, food insecurity (FI) – the lack of adequate access to food – can contribute to higher infant mortality rates even in this country, according to a study conducted by scientists at Wake Forest School of Medicine.
Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE). MPE is the accumulation of fluid between the chest wall and lungs and is accompanied by malignant cells and/or tumors.
For the first time, scientists have identified a rare population of potentially toxic senescent cells in human brains that can serve as a target for a new Alzheimer’s disease treatment.
Chronic musculoskeletal pain (CMP) – daily pain in the muscles, bones, ligaments, tendons and nerves that lasts for six months or longer – contributes to approximately 21% of worker disability issues in this country and costs $500 billion annually from lost wages, treatment and medications, according to a study conducted by Johns Hopkins University.
In an effort to develop a more effective strategy against this debilitating condition, a team of doctors and researchers at Wake Forest School of Medicine has received a four-year grant of approximately $4 million from the National Institutes of Health.
Despite the widespread use of mammography screening, the incidence of de novo metastatic breast cancer has not declined and represents 3% to 6% of new breast cancer diagnoses in high-income countries and 10% to 30% in low-income countries. De novo metastatic breast cancer refers to breast cancer that has already spread to distant sites (liver, brain, lung or bone) at a patient’s initial diagnosis and has a five-year survival rate of around 29%.
Following the Affordable Care Act (ACA) Medicaid expansion, access to bariatric surgery as a treatment for obesity increased by 31% annually for lower-income Medicaid-covered and uninsured white adults age 26 to 64 but not for Hispanic and Black adults, according to research conducted by scientists at Wake Forest School of Medicine.
Atrium Health Wake Forest Baptist and its healthtech business enterprise operated through the Innovation Quarter, iQ Healthtech Labs, are taking COVID-19 vaccination efforts to new heights with drone deliveries – the first COVID-19 vaccine drone delivery program in the country.
With the recent announcement of the RegeneratOR Test Bed to support regenerative medicine start up companies, the Wake Forest Institute for Regenerative Medicine (WFIRM) and the RegenMed Development Organization (RemDO) are embarking on the next step – to help create the future workforce.
Phase Holographic Imaging is collaborating with the RegeneratOR Test Bed, a new regenerative medicine endeavor in North Carolina, by providing its technology to help support start-up companies in the regenerative medicine space.
Small lifestyle changes really can make a big difference in improving vascular health in older adults with obesity, according to a study conducted by researchers at Wake Forest School of Medicine.
Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer. The therapy also showed a benefit in overall survival. The study findings appear online in 4Open, a journal published by EDP Sciences.
People living in the South, known as the Stroke Belt, are not only at a greater risk of having strokes, but the region is also associated with higher stroke mortality. The link between high blood pressure and stroke is well-known, and lowering blood pressure reduces stroke risk. But how can blood pressure be most effectively managed among stroke survivors, and is the use of telehealth the most effective strategy?
Wake Forest School of Medicine has received $2.8 million from The Duke Endowment to support five projects that will examine the role social determinants play in access to health care for people in North Carolina.
Wake Forest researchers and clinicians are using patient-specific tumor ‘organoid’ models as a preclinical companion platform to better evaluate immunotherapy treatment for appendiceal cancer.
RegenMed Development Organization (ReMDO) releases the results of a national survey of regenerative medicine biomanufacturing knowledge, skills, and abilities needed for successful employment in the regenerative medicine field.
The RegenMed Development Organization (ReMDO), a non-profit foundation headquartered in Winston-Salem, NC, and dedicated to advancing the regenerative medicine field nationwide, and the Wake Forest Institute for Regenerative Medicine (WFIRM), the largest regenerative medicine institute in the world, announce the launch of the RegeneratOR Test Bed.
With preseason football training on the horizon, a new study shows that head impacts experienced during practice are associated with changes in brain imaging of young players over multiple seasons.
New research shows that diet, including fish oil supplements, can alter not only the breast microbiome, but also breast cancer tumors. The study appears online in Cancer Research, a journal of the American Association for Cancer Research.
Renalytix AI plc, Atrium Health, Wake Forest Baptist Health and Wake Forest School of Medicine announced a partnership to implement an advanced clinical care model designed to improve kidney health and reduce kidney disease progression and kidney failure in high-risk populations.
As many people are making plans to enjoy the great outdoors this spring and summer, Wake Forest Baptist Health’s Wilderness Medicine experts are sharing some important information to help make it a safe and enjoyable time for the whole family.
Seth Hawkins, M.D., wilderness medicine expert, assistant professor of emergency medicine at Wake Forest Baptist and medical director for N.C. State Parks, offers the following tips.
Heart failure (HF) – when the heart can’t pump enough blood and oxygen through the body – affects approximately 6.2 million adults in the United States and is the primary cause of hospitalization in the elderly. Unfortunately, older adults with heart failure often have poor outcomes resulting in reduced quality of life, high mortality and frequent rehospitalizations.
WFIRM scientists are tackling necrotizing enterocolitis with a human placental-derived stem cell (hPSC) therapy strategy that is showing promising results.
Open Standard Industries, Inc. (OSI), manufacturer of the OSR-M1 non-valved reusable elastomeric face mask, is pleased to formally announce the launch of its first Institutional Review Board (IRB)-approved user feasibility study. The trial is being led by the departments of Biomedical Engineering and Infectious Diseases at Wake Forest School of Medicine, part of Wake Forest Baptist Health. Recruitment in the study is underway, and enrollment is expected to be completed by May 28, 2021.
Investigators at Wake Forest School of Medicine, part of Wake Forest Baptist Health, have identified a set of new genetic markers that could potentially lead to new personalized treatments for lung cancer.
According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one of every four new breast cancer cases in the United States. If left untreated, DCIS has the potential to evolve into invasive cancer, so many patients choose to have breast-conserving surgery or mastectomy after a diagnosis.
Personalized medicine research for aggressive abdominal cancers receives a boost with a new $2.5 million grant award from the National Cancer Institute that highlights research efforts by the Wake Forest Organoid Research Center (WFORCE).
The fear, anxiety and stress associated with the COVID-19 pandemic has taken a toll on mental health. But a new study suggests these symptoms may be alleviated through safe and convenient online mindfulness practices.
The Wake Forest Institute for Regenerative Medicine is investigating how cats with chronic kidney disease could someday help inform treatment for humans.
For people who are overweight or obese and have type 2 diabetes, the first line of treatment is usually lifestyle intervention, including weight loss and increased physical activity. While this approach has cardiovascular benefit for many, it can be detrimental for people who have poor blood sugar control, according to a study conducted by researchers at Wake Forest School of Medicine.
There is a growing recognition in health care that social factors such as racial bias, access to care and housing and food insecurity, have a significant impact on people’s health. Compounding and amplifying those underlying inequalities are the ongoing disruptions related to the COVID-19 pandemic and social unrest in our country.
Among stroke survivors, 25% are readmitted to the hospital within 90 days, 73% have a fall within six months, and 50% do not have their blood pressures controlled, according to Pamela W. Duncan, Ph.D., professor of neurology for Wake Forest School of Medicine, part of Wake Forest Baptist Health.
Most doctors would agree that advanced care planning (ACP) for patients, especially older adults, is important in providing the best and most appropriate health care over the course of a patient’s life.
In a recent clinical trial from Wake Forest Baptist Health, researchers showed that mindfulness-based stress reduction (MBSR) may provide benefit to people with migraine.
Despite advances in cancer treatment, disparities in cancer outcomes are prevalent, especially for minority, underserved and rural populations. With a $775,000 one-year grant from the National Cancer Institute (NCI), researchers at Wake Forest Baptist’s Comprehensive Cancer Center are working to reduce those disparities.
Even before the pandemic and the presidential election, Americans reported some of the highest perceived levels of stress in the world, according to the American Psychological Association.
Newborns and young infants are particularly susceptible to the flu and are six times more likely to die from the infection than older children. Currently there is no flu vaccine available for babies less than 6 months old.
Scientists at Wake Forest School of Medicine have recorded real time changes in dopamine and serotonin levels in the human brain that are involved with perception and decision-making. These same neurochemicals also are critical to movement disorders and psychiatric conditions, including substance abuse and depression.
A new era of health care was ushered in today as Atrium Health and Wake Forest Baptist Health, including Wake Forest School of Medicine, officially joined together as a single enterprise, Atrium Health. Both health systems are renowned for their clinical expertise and the school of medicine is nationally recognized for its medical education programs and research. With the strategic combination now complete, the collective vision to transform medical education, expand patient-centered research and innovation, and define the next generation of clinical excellence becomes a reality.
A study conducted at Wake Forest Baptist Health shows that on-scene use of a new protocol and advanced diagnostic equipment can help paramedics better identify patients at high risk for adverse cardiac events.
– Wake Forest Baptist Health has received a $1.2 million grant from the U.S. Health Resources and Services Administration (HRSA) to help improve rural cardiovascular care in Wilkes County.